In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Doxycycline Hyclate (100 mg) Drug Master File in Korea (Doxycycline Hyclate (100 mg) KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Doxycycline Hyclate (100 mg). The MFDS reviews the Doxycycline Hyclate (100 mg) KDMF as part of the drug registration process and uses the information provided in the Doxycycline Hyclate (100 mg) KDMF to evaluate the safety and efficacy of the drug.
After submitting a Doxycycline Hyclate (100 mg) KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Doxycycline Hyclate (100 mg) API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Doxycycline Hyclate (100 mg) suppliers with KDMF on PharmaCompass.